Ovette Villavicencio, MD, PHD - Catalina Eye Care
526
page-template-default,page,page-id-526,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-16.5,qode-theme-bridge,wpb-js-composer js-comp-ver-5.5.2,vc_responsive
 

Ovette Villavicencio, MD, PHD

Dr. Ovette Villavicencio

Dr. Ovette Villavicencio specializes in cataract surgery, corneal transplantation, and LASIK refractive surgery and is trained in all disciplines of comprehensive ophthalmology. A Magna Cum Laude graduate of Illinois Wesleyan University with a B.A. degree in chemistry and business administration, Dr. Villavicencio earned his Doctor of Philosophy with a concentration on optical storage materials and Doctor of Medicine degrees at the University of Arizona. After completing a medical internship and ophthalmology residency at the University of Arizona, he went on to complete a fellowship in corneal transplantation, refractive surgery, and external ophthalmic diseases at the prestigious Price Vision Group in Indianapolis, IN.

Dr. Villavicencio’s training included all facets of corneal transplantation including the revolutionary Descemet’s Membrane Endothelial Keratoplasty (DMEK), an ultra-thin partial thickness corneal transplant for the treatment of Fuchs’ Dystrophy and other corneal diseases. He also performs Deep Anterior Lamellar Keratoplasty (DALK), full thickness corneal transplants, and keratoprostheses.

Dr. Villavicencio and Catalina Eyecare are excited to announce the FDA approval of a new device for the treatment of keratoconus using Corneal Collagen Cross-Linking, which can slow or even stop the progression of keratoconus.  Avedro, Inc., an ophthalmic pharmaceutical and medical device company, has recently received approval from the U.S. Food and Drug Administration (FDA) for Photrexa Viscous, Photrexa and the KXL Collagen Cross-Linking System.  Dr. Villavicencio is proud to have been part of a nationwide team involved in the Avedro study, which resulted in the FDA approval of this new device and treatment.  Dr. Villavicencio has been performing Collagen Cross-Linking since 2014, as part of the KXL Study in Indianapolis, IN.  Since late 2016, Dr. Villavicencio has been offering this technology to the Tucson and Southern Arizona area.

A member of the American Academy of Ophthalmology and the Cornea Society, Dr. Villavicencio has authored numerous research publications and book chapters. He is committed to the highest standards of patient care and successful outcomes.